THOUSAND OAKS BIOPHARMACEUTICALS
Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.
THOUSAND OAKS BIOPHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2017-03-01
Status:
Active
Contact:
+86 0513-68067603
Email Addresses:
[email protected]
Total Funding:
340.62 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Content Delivery Network Mobile Non Scaleable Content Euro ASP.NET IIS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
CDH Investments
CDH Investments investment in Venture Round - Thousand Oaks Biopharmaceuticals
Highlight Capital
Highlight Capital investment in Venture Round - Thousand Oaks Biopharmaceuticals
GoldStone Investment
GoldStone Investment investment in Venture Round - Thousand Oaks Biopharmaceuticals
Hillhouse Capital Group
Hillhouse Capital Group investment in Venture Round - Thousand Oaks Biopharmaceuticals
Jinshi Investment
Jinshi Investment investment in Series C - Thousand Oaks Biopharmaceuticals
China State-Owned Capital Venture Investment Fund
China State-Owned Capital Venture Investment Fund investment in Series C - Thousand Oaks Biopharmaceuticals
CDH Investments
CDH Investments investment in Series C - Thousand Oaks Biopharmaceuticals
Honghui Capital
Honghui Capital investment in Series C - Thousand Oaks Biopharmaceuticals
GL Ventures
GL Ventures investment in Series C - Thousand Oaks Biopharmaceuticals
CICC Healthcare Investment Fund
CICC Healthcare Investment Fund investment in Series C - Thousand Oaks Biopharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Thousand Oaks Biopharmaceuticals investment in Series A - MabPlex International | 400 M CNY |